Biblio

Found 360 results
Author Keyword Title Type [ Year(Asc)]
2010
M. P. Smerdel, Steffensen, K. D., Waldstrom, M., Brandslund, I., and Jakobsen, A., The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab, Gynecol Oncol, vol. 118, pp. 167-71, 2010.
H. Mackay, Brady, M. F., Oza, A. M., Reuss, A., Pujade-Lauraine, E., Swart, A. Marie, Siddiqui, N. Ahmad, Colombo, N., Bookman, M. A., Pfisterer, J., du Bois, A., and InterGroup, G. Cancer, Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer, Int J Gynecol Cancer, vol. 20, pp. 945-52, 2010.
M. Quinn, Progress in ovarian cancer trials: the GCIG consensus model–is bigger, better?, Gynecol Oncol, vol. 119, pp. 5-6, 2010.
S. Takakura, Takano, M., Takahashi, F., Saito, T., Aoki, D., Inaba, N., Noda, K., Sugiyama, T., Ochiai, K., and Group, J. Gynecologi, Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study, Int J Gynecol Cancer, vol. 20, pp. 240-7, 2010.
T. Högberg, Signorelli, M., de Oliveira, C. F., Fossati, R., Lissoni, A., Sorbe, B., Andersson, H., Grenman, S., Lundgren, C., Rosenberg, P., Boman, K., Tholander, B., Scambia, G., Reed, N. Simon, Cormio, G., Tognon, G., Clarke, J., Sawicki, T., Zola, P., and Kristensen, G. B., Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–results from two randomised studies, Eur J Cancer, vol. 46, pp. 2422-31, 2010.
A. Fagotti, Fanfani, F., Vizzielli, G., Gallotta, V., Ercoli, A., Paglia, A., Costantini, B., Vigliotta, M., Scambia, G., and Ferrandina, G., Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?, Gynecol Oncol, vol. 116, pp. 72-7, 2010.
S. A. Welch, Hirte, H., Elit, L., Schilder, R. J., Wang, L., Macalpine, K., Wright, J. J., and Oza, A. M., Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium, Int J Gynecol Cancer, vol. 20, pp. 787-93, 2010.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.
2009
P. Blake, Swart, A. Marie, Orton, J., Kitchener, H. C., Whelan, T., Lukka, H., Eisenhauer, E., Bacon, M., Tu, D., Parmar, M. K. B., Amos, C., Murray, C., and Qian, W., Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis., Lancet, vol. 373, no. 9658, pp. 137-46, 2009.
S. Pignata, Scambia, G., Savarese, A., Breda, E., Sorio, R., Pisano, C., Lorusso, D., Cognetti, F., A. Lombardi, V., Gebbia, V., Scollo, P., Morabito, A., Signoriello, G., and Perrone, F., Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial, Oncology, vol. 76, pp. 49-54, 2009.
N. Katsumata, Yasuda, M., Takahashi, F., Isonishi, S., Jobo, T., Aoki, D., Tsuda, H., Sugiyama, T., Kodama, S., Kimura, E., Ochiai, K., Noda, K., and Group, J. Gynecologi, Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial, Lancet, vol. 374, pp. 1331-8, 2009.
H. C. Kitchener, Swart, A. Marie, Qian, Q., Amos, C., and Parmar, M. K. B., Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study., Lancet, vol. 373, no. 9658, pp. 125-36, 2009.
H. C. Kitchener and Trimble, E. L., Endometrial cancer state of the science meeting., Int J Gynecol Cancer, vol. 19, no. 1, pp. 134-40, 2009.
M. A. Bookman, Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M. Leonard, Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., Mutch, D. G., Burger, R. A., Swart, A. Marie, Trimble, E. L., Accario-Winslow, C., and Roth, L. M., Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup., J Clin Oncol, vol. 27, no. 9, pp. 1419-25, 2009.
I. Ray-Coquard, Weber, B., Cretin, J., Haddad-Guichard, Z., Levy, E., Hardy-Bessard, A. C., Gouttebel, M. C., Geay, J. - F., Aleba, A., Orfeuvre, H., Agostini, C., Provencal, J., Ferrero, J. M., Fric, D., Dohollou, N., Paraiso, D., Salvat, J., Pujade-Lauraine, E., and Group, G. I. N. E. C. O., Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group, Br J Cancer, vol. 100, pp. 601-7, 2009.
E. Petru, Luck, H. J., Stuart, G. C. E., Gaffney, D. K., Millan, D., Vergote, I. B., and InterGroup, G. Cancer, Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system, Eur J Obstet Gynecol Reprod Biol, vol. 143, pp. 69-74, 2009.
A. M. Poveda and Vermorken, J. B., The International Symposium on Advanced Ovarian Cancer. February 27, 2009, Spain., Int J Gynecol Cancer, vol. 19 Suppl 2, p. S1, 2009.
M. Signorelli, Lissoni, A., Cormio, G., Katsaros, D., Pellegrino, A., Selvaggi, L., Ghezzi, F., Scambia, G., Zola, P., Grassi, R., Milani, R., Giannice, R., Caspani, G., Mangioni, C., Floriani, I., Rulli, E., and Fossati, R., Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study, Ann Surg Oncol, vol. 16, pp. 3431-41, 2009.
D. K. Gaffney, du Bois, A., Narayan, K., Reed, N. Simon, Toita, T., Pignata, S., Blake, P., Portelance, L., Sadoyze, A., Potter, R., Colombo, A., Randall, M., Mirza, M. R., and Trimble, E. L., Patterns of care for radiotherapy in vulvar cancer: a Gynecologic Cancer Intergroup study, Int J Gynecol Cancer, vol. 19, pp. 163-7, 2009.
C. Pisano, Morabito, A., Sorio, R., Breda, E., Lauria, R., Gebbia, V., Scaltriti, L., Scalone, S., Zagonel, V., Greggi, S., Beneduce, G., Losito, S., Gallo, C., Di Maio, M., Forestieri, V., and Pignata, S., A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial, Cancer Chemother Pharmacol, vol. 64, pp. 1021-7, 2009.
Y. Watanabe, Kitagawa, R., Aoki, D., Takeuchi, S., Sagae, S., Sakuragi, N., Yaegashi, N., and Group, D. Committee, Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group, Gynecol Oncol, vol. 115, pp. 456-9, 2009.
W. Small, du Bois, A., Bhatnagar, S., Reed, N. Simon, Pignata, S., Potter, R., Randall, M., Mirza, M., Trimble, E. L., Gaffney, D. K., and InterGroup, G. Cancer, Practice patterns of radiotherapy in endometrial cancer among member groups of the Gynecologic Cancer Intergroup, Int J Gynecol Cancer, vol. 19, pp. 395-9, 2009.
I. B. Vergote, Calvert, A. H., Kania, M., Kaiser, C., Zimmermann, A. Hayden, and Sehouli, J., A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer, Eur J Cancer, vol. 45, pp. 1415-23, 2009.
E. Pujade-Lauraine, Mahner, S., Kaern, J., Gebski, V., Heywood, M., Vasey, P. A., Reinthaller, A., Vergote, I. B., Pignata, S., and Ferrero, A., A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer: CALYPSO study of the Gynecologic Cancer Intergroup., J Clin Oncol , vol. 27, no. 18, 2009.
T. Sugiyama, Kumagai, S., and Hatayama, S., [Treatments of epithelial ovarian cancer by histologic subtype], Gan To Kagaku Ryoho, vol. 36, pp. 187-92, 2009.

Pages